Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMontovani, Andrea-
dc.contributor.authorRuiz-Aliseda, Francisco-
dc.date.accessioned2012-01-17T21:56:06Z-
dc.date.available2012-01-17T21:56:06Z-
dc.date.issued2012-01-17T21:56:06Z-
dc.identifier.urihttp://hdl.handle.net/2451/31447-
dc.description.abstractThe recent years have exhibited a burst in the amount of collaborative activities among rms selling complementary products. This paper aims at providing a ra- tionale for such a large extent of collaboration ties among complementors. To this end, we analyze a game in which the two producers of a certain component have the possibility to form pairwise collaboration ties with each of the two producers of a complementary component. Once ties are formed, each of the four rms de- cides how much to invest in improving the quality of the match with each possible complementor, under the assumption that a rm with a collaboration link with a complementor puts some weight on the complementor s pro t when making invest- ment decisions. Once investment choices have taken place, all rms choose prices for their respective components in a noncooperative manner. In equilibrium, rms end up forming as many collaboration ties as it is possible, although they would all prefer a scenario where collaboration were forbidden. In addition, a social planner would also prefer such a scenario to the one arising in equilibrium. We show that the result that collaboration is ine¢ cient for rms and society does not depend on whether collaboration ties are formed in an exclusive manner: in fact, exclusivity would only worsen the situation.en
dc.relation.ispartofseriesWorking Papers;11_31-
dc.subjectSystems Competition, Complementary Products, Interoperability, Collaboration, Link, Co-opetition, Exclusivityen
dc.titleEquilibrium Innovation Ecosystems: The Dark Side of Collaborating with Complementorsen
Appears in Collections:NET Institute Working Papers Series

Files in This Item:
File Description SizeFormat 
Montovani_Ruiz_11_31.pdf269.71 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.